Buchang Pharma

Heze, China Founded: 2001 • Age: 25 yrs
Chinese medicines are researched, developed, manufactured, and supplied.
Annual revenue $1.5B Latest available
Total funding - 3 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Buchang Pharma

Buchang Pharma is a company based in Heze (China) founded in 2001. Buchang Pharma offers products and services including Cardiovascular Drugs and Diabetes Medications.

  • Headquarter Heze, China
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Shandong Buchang Pharmaceutical Co., Ltd
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.49 B (USD)
    -16.75
    as on Dec 31, 2024
  • Net Profit
    -$75.87 M (USD)
    -273.62
    as on Dec 31, 2024
  • EBITDA
    $178.1 M (USD)
    -21.39
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    AIF Capital

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Buchang Pharma

Buchang Pharma offers a comprehensive portfolio of products and services, including Cardiovascular Drugs and Diabetes Medications.

Product name locked
Category locked
Primary

Drugs are developed for treating heart and cerebral vessel conditions using traditional Chinese medicine approaches.

Product name locked
Category locked
Locked

Medications are provided for diabetes management as part of the company's focus on major disease areas.

Funding Insights of Buchang Pharma

Investors in Buchang Pharma

Buchang Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include AIF Capital and Grand Yangtze.

All
Venture Fund
Investor Description Founded Year Domain Location
Investment funding and expertise for emerging businesses in Asia.
Locked Locked Locked
Private equity investments are managed by the company.
Locked Locked Locked
Premium access

Investor details for Buchang Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Buchang Pharma

Investments
Premium access

Investment portfolio details for Buchang Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Buchang Pharma

Premium access

Detailed financials for Buchang Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Buchang Pharma Comparisons

Buchang Pharma Primary company
Description
Chinese medicines are researched, developed, manufactured, a...
Location
Heze, China
Founded Year
2001
Annual Revenue
$1.49 B (USD)
Net Profit
-$75.87 M (USD)
EBITDA
$178.1 M (USD)
Employees
Not available
Premium access

Peer comparison for Buchang Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Buchang Pharma

Premium access

Detailed competitors of Buchang Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Buchang Pharma

Premium access

Complete news archive for Buchang Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Buchang Pharma

Buchang Pharma was founded in 2001 and raised its 1st funding round 7 years after it was founded.

Buchang Pharma is headquartered in Heze, China. It is registered at Heze, Shandong, China.

Annual revenue of Buchang Pharma is $1.49B as on Dec 31, 2024.

Buchang Pharma, based in Heze, focuses on providing healthcare solutions, and alternative medicine products. Researcher, developer, manufacturer, and supplier of chinese medicines. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Buchang Pharma offers Cardiovascular Drugs and Diabetes Medications.

Buchang Pharma has 2 investors. Key investors include AIF Capital, and Grand Yangtze.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available